Cefpodoxime

Cefpodoxime Struktur
80210-62-4
CAS-Nr.
80210-62-4
Englisch Name:
Cefpodoxime
Synonyma:
CPDX;Cefpodoxima;Cefpodoxime;Cefpodoximum;Unii-7R4F94tvgy;Cefpodoxime sulfate;Cefpodoximum [latin];Cefpodoxima [spanish];Cefpodoxime USP/EP/BP;Cefpodoxime tablet 200mg
CBNumber:
CB9511604
Summenformel:
C15H17N5O6S2
Molgewicht:
427.46
MOL-Datei:
80210-62-4.mol

Cefpodoxime Eigenschaften

Schmelzpunkt:
200-202°C
Dichte
1.78±0.1 g/cm3(Predicted)
RTECS-Nr.
XI0367365
storage temp. 
Sealed in dry,Store in freezer, under -20°C
Löslichkeit
Soluble in DMSO
pka
2.77±0.50(Predicted)
Sensitive 
Light Sensitive
BRN 
6021381
Stabilität:
Hygroscopic
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
Kennzeichnung gefährlicher Xn
R-Sätze: 42/43
S-Sätze: 22-36/37-45
WGK Germany  3
Bildanzeige (GHS) GHS hazard pictograms
Alarmwort Achtung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H317 Kann allergische Hautreaktionen verursachen. Sensibilisierung der Haut Kategorie 1A Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P261, P272, P280, P302+P352,P333+P313, P321, P363, P501
H334 Kann bei Einatmen Allergie, asthmaartige Symptome oder Atembeschwerden verursachen. Sensibilisierung der Atemwege Kategorie 1 Achtung GHS hazard pictogramssrc="/GHS08.jpg" width="20" height="20" /> P261, P285, P304+P341, P342+P311,P501
Sicherheit
P261 Einatmen von Staub vermeiden.
P280 Schutzhandschuhe/Schutzkleidung/Augenschutz tragen.
P342+P311 Bei Symptomen der Atemwege: GIFTINFORMATIONSZENTRUM/Arzt/... (geeignete Stelle für medizinische Notfallversorgung vom Hersteller/Lieferanten anzugeben) anrufen.

Cefpodoxime Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

Off-White Solid

Verwenden

A metabolite of Cefpodoxime Proxetil. An antibacterial.

Definition

ChEBI: A third-generation cephalosporin antibiotic with methoxymethyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamino substituents at positions 3 and 7, respectively, of the cephem skeleton. Given by mouth as its proxetil ester prodrug, it is used to treat acute otitis media, pharyngitis, and sinusitis.

Antimicrobial activity

It is stable to a wide range of plasmid-mediated β-lactamases. It induces the chromosomal β-lactamases of Ps. aeruginosa, Enterobacter spp., S. marcescens and Citrobacter spp., but is a less potent inducer than cefoxitin.

Pharmakokinetik

Oral absorption: c. 50%
Cmax 200 mg oral: 2.1 mg/L after 3 h
Plasma half-life: c. 2.2 h
Volume of distribution: c. 35 L
Plasma protein binding: 20–30%
Absorption and distribution
The ester is rapidly hydrolyzed to the parent compound in the small intestine. Bioavailability increases to 65% if taken with food, but antacids and H2-receptor antagonists reduce absorption. Unabsorbed drug is hydrolyzed and excreted in the feces.
It is well distributed and penetrates well into tissues (including lung tissue) and inflammatory exudate to achieve concentrations inhibitory to common pathogens.
Metabolism and excretion
The hydrolyzed prodrug is not subject to further metabolism. About 80% of the absorbed compound (30–40% of the original dose) appears in the urine over 24 h. Excretion is by glomerular filtration and tubular secretion; probenecid delays secretion and increases the peak plasma concentration.
Metabolism and excretion
The hydrolyzed prodrug is not subject to further metabolism. About 80% of the absorbed compound (30–40% of the original dose) appears in the urine over 24 h. Excretion is by glomerular filtration and tubular secretion; probenecid delays secretion and increases the peak plasma concentration.

Clinical Use

Cefpodoxime has been used principally for the treatment of upper and lower respiratory tract infections in children and adults.

Nebenwirkungen

The drug is well tolerated, but gastrointestinal disturbance with diarrhea is common. Pseudomembranous colitis has been reported occasionally. Other side effects are those common to cephalosporins.

Cefpodoxime Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Cefpodoxime Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 133)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21691 55
Standardpharm Co. Ltd.
86-714-3992388
overseasales1@yongstandards.com United States 14336 58
BOC Sciences
+1-631-485-4226
inquiry@bocsci.com United States 19553 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427
sales@conier.com China 49390 58
career henan chemical co
+86-0371-86658258 15093356674;
factory@coreychem.com China 29826 58
Shaanxi Dideu Medichem Co. Ltd
+86-029-89586680 +86-18192503167
1026@dideu.com China 9320 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250
1026@dideu.com China 29220 58
AFINE CHEMICALS LIMITED
0571-85134551
info@afinechem.com CHINA 15377 58
Hebei Guanlang Biotechnology Co,.LTD
+8619930503252
daisy@crovellbio.com China 5964 58
Dayang Chem (Hangzhou) Co.,Ltd.
571-88938639 +8617705817739
info@dycnchem.com CHINA 52867 58

80210-62-4()Verwandte Suche:


  • (6R,7R)-7α-[[(2-Aminothiazol-4-yl)[(Z)-methoxyimino]acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • (7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetyl]amino]-3-methoxymethylcepham-3-ene-4-carboxylic acid
  • CPDX
  • 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-, (6R-(6alpha,7beta(Z)))-
  • Cefpodoxima
  • Cefpodoxima [spanish]
  • Cefpodoximum
  • Cefpodoximum [latin]
  • Unii-7R4F94tvgy
  • (6R,7R)-7-{2-(2-Amino-4-thiazolyl)-2-[(Z)-methoxyimino]acetamido}-3-(methoxymethyl)-3-cephem-4-carboxylate
  • Cefpodoxime sulfate
  • (6R-(6alpha,7beta(Z)))-7-(((2-Amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • Cefpodoxime
  • (6R,7R)-7α-[[(2-Amino-4-thiazolyl)[(Z)-methoxyimino]acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]octa-2-ene-2-carboxylic acid
  • Cefpodoxime-D3Acid(98%,99Atom%D)
  • Cefpodoxime Proxetil impurity 1/Cefpodoxime Proxetil EP Impurity A/ Cefpodoxime Acid/(6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • Cefpodoxime Proxetil EP Impurity A (Cefpodoxime Acid)
  • Cefpodoxime proxetil Impurity A:( (6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid(Cefpodoxime Acid)
  • (6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • Cefpodoxime Proxetil Impurity 1(Cefpodoxime Proxetil EP Impurity A)
  • Cefpodoxime Proxetil EP Impurity A
  • 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-, (6R,7R)-
  • Cefpodoxime Proxetil Impurity 1(EP Impurity A)
  • Cefpodoxime USP/EP/BP
  • Cefpodoxime D3 AcidQ: What is Cefpodoxime D3 Acid Q: What is the CAS Number of Cefpodoxime D3 Acid Q: What is the storage condition of Cefpodoxime D3 Acid Q: What are the applications of Cefpodoxime D3 Acid
  • CefpodoximeAcidQ: What is CefpodoximeAcid Q: What is the CAS Number of CefpodoximeAcid Q: What is the storage condition of CefpodoximeAcid Q: What are the applications of CefpodoximeAcid
  • Cefpodoxime tablet 200mg
  • Cefpodoxime,Bacterial,gram-negative bacteria,R-3763,Cefpodoxime (free acid),Cefpodoxime acid,Antibiotic,R 3763,Inhibitor,R3763,gram-positive bacteria,inhibit
  • 80210-62-4
  • Various Metabolites and Impurities
  • Heterocycles
  • Sulfur & Selenium Compounds
  • Intermediates & Fine Chemicals
  • Metabolites & Impurities
  • Pharmaceuticals
Copyright 2019 © ChemicalBook. All rights reserved